Skip to main content
. 2022 Nov;383(2):137–148. doi: 10.1124/jpet.122.001332

Fig. 1.

Fig. 1.

Mitofusin activators used in these studies. (top) Chimera C is the prototype for first generation triazolurea class of mitofusn activators that are not suitable for in vivo studies. (Middle) trans-MiM111 and (lower) CPR1-B are second generation phenylhexanamide mitofusin activators that have stereoisomer-specific activity and can be used in vivo.